BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Inex Pharmaceuticals Corporation

INEX Pharmaceuticals Corporation is a biopharmaceutical company that utilizes proprietary drug delivery systems and therapeutic compounds to increase the effectiveness and reduce the side-effects of anti-cancer therapies.

INEX's strategy has been to develop technology capable of making anti-cancer drugs more effective and reducing their side-effects, thus giving these drugs a competitive advantage in the marketplace. The basic approach has been to encapsulate the drugs in a lipid envelope that is carried through the bloodstream and delivered to disease sites where the drugs are released to carry out their therapeutic action.


Contact Details:
100 - 8900 Glenlyon Parkway Glenlyon Business Park
Burnaby
British Columbia
V5J 5JB
Canada
Tel:604 419 3200
Fax:604 419 3204
Email:
WWW:

www.inexpharm.com/




Loading...

Recent Publications by Inex Pharmaceuticals Corporation:

Methods for the preparation of protein-oligonucleotide-lipid constructs.
A mixture of ionizable cationic lipids, steric barrier lipids, and...
13th July, 2006
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, Bioconjug Chem. 2006 Mar-Apr;17(2):451-8.
DOI Direct Link
Micelles as intermediates in the preparation of protein-liposome conjugates.
A method for preparing protein-liposome conjugates based on micelles as...
13th July, 2006
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, Bioconjug Chem. 2006 Mar-Apr;17(2):438-50.
DOI Direct Link
Reliability of preparation procedure for sphingosomal vincristine.
PURPOSE: The reliability of the preparation procedure for sphingosomal...
31st December, 2005
Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada. Am J Health Syst Pharm. 2005 Aug 1;62(15):1606-12.
DOI Direct Link
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.
Vinorelbine (VRL) is a particularly lipophilic member of the vinca...
13th August, 2005
Inex Pharmaceuticals Corporation, 200-8900 Glenlyon Parkway, Glenlyon J Pharm Sci. 2005 May;94(5):1024-38.
DOI Direct Link
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid.
Polyethylene glycol (PEG) is used widely in the pharmaceutical industry to...
6th April, 2005
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, J Pharmacol Exp Ther. 2005 Mar;312(3):1020-6. Epub 2004 Nov 3.
DOI Direct Link

View more Inex Pharmaceuticals Corporation research publications.

BioNews Results for Inex Pharmaceuticals Corporation:

Tekmira Pharmaceuticals Expands Executive Management Team
TradingMarkets:  Sep 29 2008 3:07PM Matching: inex pharmaceuticals

Inex Pharmaceuticals Corporation Patents:

US Patent No.Title
7247316 Compositions and methods for treating lymphoma
6287591 Charged therapeutic agents encapsulated in lipid particles containing four lipid components
6110745 Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
5981501 Methods for encapsulating plasmids in lipid bilayers
5976567 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer

View more Inex Pharmaceuticals Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 188 times since April 2007, the link to the organisation's website has been followed 48 times

Recent Search Terms used to find this page: Inex Pharmaceuticals Corporation | Inex pharmaceuticals Glenlyon park | Inex Pharmaceuticals Corporation | Inex Pharmaceuticals Corporation burnaby bc | .

Search for more companies in Burnaby

Search for more companies in British Columbia



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Inex Pharmaceuticals Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.